Table: Sumitomo Pharma -2022/23 div forecast
Mar 3 (Reuters) -
Sumitomo Pharma Co., Ltd.
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full year to Full year to
Mar 31, 2023 Mar 31, 2023
LATEST PREVIOUS
FORECAST FORECAST
Annual Div 21.00 yen 28.00 yen
-Q2 Div 14.00 yen 14.00 yen
-Q4 Div 7.00 yen 14.00 yen
NOTE - Sumitomo Pharma Co., Ltd..
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in 2006
allowed companies to pay and report dividends on a quarterly basis.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4506.T
Recent news on Sumitomo Pharma
See all newsSumitomo Pharma America Announces First Patient Receives Treatment In Phase 1/2A Study For Investigational Therapy Dsp-3077 For Retinitis Pigmentosa
Regarding A Report Concerning Sumitomo Pharma ( Company's Views On Gcr August 7 Report)
Brief: Sumitomo Pharma - Gotham City Research's August 3 Report Contains Numerous Statements That Are Clearly Inconsistent With Facts
Brief: Gotham City Research Holds Short Positions In Sumitomo Chemical And Sumitomo Pharmaceutical
Table: Sumitomo Pharma -Q1 group results (IFRS)